StockData
MiNK Therapeutics, Inc. logo

MiNK Therapeutics, Inc. (INKT) stock

INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$9.29−0.06 (-0.70%)

Close on Nov 17, 2026Market cap $47.38MP/E –Yield –

MiNK Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

MiNK Therapeutics's price to book ratio was 11.2× on Jan 31, 2023.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 202311.2×−1.6
2022Dec 30, 202212.8×–

More MiNK Therapeutics figures

See a number that looks wrong?